Cellulitis: Difference between revisions

From IDWiki
()
No edit summary
 
(One intermediate revision by the same user not shown)
Line 1: Line 1:
== Background ==

*Infection of superficial skin and skin structures
*Infection of superficial skin and skin structures


==Etiology==
===Microbiology===


*''[[Streptococcus pyogenes]]'' (much more common)
*''[[Streptococcus pyogenes]]'' (much more common)
Line 14: Line 16:
**Butchers: ''[[Erysipelothrix]]'' (erysipeloid)
**Butchers: ''[[Erysipelothrix]]'' (erysipeloid)


==Clinical Manifestations==
==Differential Diagnosis==

*Hot, red, swollen, tender area of skin with poorly demarcated margins
*With or without pus and/or bullae
*Legs more common than elsewhere

== Diagnosis ==

* Clinical based on typical appearance

== Differential Diagnosis ==


*Skin and soft tissue infections
*Skin and soft tissue infections
Line 30: Line 42:
**[[Acute inflammatory edema]]
**[[Acute inflammatory edema]]
*For an exhaustive list, see [[Cellulitis mimickers]]
*For an exhaustive list, see [[Cellulitis mimickers]]

==Clinical Manifestations==

*Hot, red, swollen, tender area of skin with poorly demarcated margins
*With or without pus and/or bullae
*Legs more common than elsewhere


==Management==
==Management==
Line 41: Line 47:
*Source control: drain any abscess
*Source control: drain any abscess
*Antibiotics for 5-7 days
*Antibiotics for 5-7 days
*Purulent SSTI
**Purulent SSTI
**Cephalexin or cefazolin are good first-line empiric choices
***[[Cephalexin]] or [[cefazolin]] are good first-line empiric choices
**Doxycycline or vancomycin can also be considered
***Doxycycline or vancomycin can also be considered
*Non-purulent SSTI
**Non-purulent SSTI
**Cephalexin 500mg po qid or cefazolin 1-2g IV q8h for 5-7 days
***[[Cephalexin]] 500 mg po qid or [[cefazolin]] 1-2 g IV q8h for 5-7 days
**If penicillin allergy
***If penicillin allergy
***Clindamycin300mg po qid
****[[Clindamycin]] 300 mg po qid
***Moxifloxacin 400mg po daily
****[[Moxifloxacin]] 400 mg po daily
***Linezolid 600mg po bid
****[[Linezolid]] 600 mg po bid
***Clindamycin 600mg IV tid
****[[Clindamycin]] 600 mg IV tid
***Vancomycin 1g IV q12h
****[[Vancomycin]] 1 g IV q12h
*Non-resolving cellulitis
*Non-resolving cellulitis
**Bug-drug mismatch
**Bug-drug mismatch
Line 61: Line 67:
***Shellfish, meats, hides
***Shellfish, meats, hides
***IV drug use
***IV drug use
***Animal or human bites
***[[Animal bites|Animal or human bites]]
**Poor adherence/absorption/distribution
**Poor adherence/absorption/distribution
**Wrong diagnosis
**Wrong diagnosis
**Impatience!
**Impatience!
*Complications of infection
*Complications of infection
**Abscess (drain it)
**[[Abscess]] (drain it)
**Deep infection
**Deep infection
**Metastasis
**Metastasis
Line 73: Line 79:


*May be indicated for patients with recurrent cellulitis
*May be indicated for patients with recurrent cellulitis
*Penicillin V 250 mg po bid
*[[Penicillin V]] 250 mg po bid
*Read more: Oh CC ''et al''. [https://doi.org/10.1016/j.jinf.2014.02.011 Antibiotic prophylaxis for preventing recurrent cellulitis: A systematic review and meta-analysis]. ''J Infect''. 2014;69(1):26-34.
*Read more: Oh CC ''et al''. [https://doi.org/10.1016/j.jinf.2014.02.011 Antibiotic prophylaxis for preventing recurrent cellulitis: A systematic review and meta-analysis]. ''J Infect''. 2014;69(1):26-34.



Latest revision as of 17:46, 14 July 2022

Background

  • Infection of superficial skin and skin structures

Microbiology

Clinical Manifestations

  • Hot, red, swollen, tender area of skin with poorly demarcated margins
  • With or without pus and/or bullae
  • Legs more common than elsewhere

Diagnosis

  • Clinical based on typical appearance

Differential Diagnosis

Management

  • Source control: drain any abscess
  • Antibiotics for 5-7 days
  • Non-resolving cellulitis
    • Bug-drug mismatch
    • Resistance
    • Poor antibiotic choice
    • Unusual organism
    • Poor adherence/absorption/distribution
    • Wrong diagnosis
    • Impatience!
  • Complications of infection
    • Abscess (drain it)
    • Deep infection
    • Metastasis

Prophylaxis